BCR and HIV infectious disease: To test this, we used publicly available data primarily from the Observed Antibody Space (OAS) database (Kovaltsuk et al., 2018) to survey measurable evolution in BCR datasets from 99 human subjects in 21 studies spanning 10 conditions including HIV infection, Ebola virus infection, and healthy controls (Table 1).